Triasima Portfolio Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,870
Closed -$2.24M 138
2025
Q1
$2.24M Sell
23,870
-1,256
-5% -$112K 0.44% 78
2024
Q4
$2.28M Buy
25,126
+894
+4% +$85.3K 0.44% 71
2024
Q3
$2.52M Buy
24,232
+10,232
+73% +$1.04M 0.57% 58
2024
Q2
$1.36M Buy
+14,000
New +$1.29M 0.12% 94
2022
Q1
Sell
-2,400
Closed -$205K 154
2021
Q4
$205K Buy
+2,400
New +$187K 0.01% 153
2021
Q2
Sell
-4,800
Closed -$378K 182
2021
Q1
$378K Hold
4,800
0.02% 151
2020
Q4
$410K Buy
+4,800
New +$397K 0.02% 139

Other funds holding CL

Triasima Portfolio Management's CL Position: Q2 2025 in Review

Triasima Portfolio Management sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 23,870 shares — an estimated $2.24M sold.

Triasima Portfolio Management first reported a position in CL in Q4 2020 and held it in 7 quarters. The position peaked at $2.52M in Q3 2024. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Triasima Portfolio Management reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
  • Triasima Portfolio Management sold 23,870 Colgate-Palmolive shares in Q2 2025, an estimated $2.24M.
  • Triasima Portfolio Management first reported a position in Colgate-Palmolive in Q4 2020 and held it in 7 quarters.
  • Triasima Portfolio Management's Colgate-Palmolive position peaked at $2.52M in Q3 2024.
  • 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Triasima Portfolio Management's 13F filing for Q2 2025, filed 23 Jul 2025.